These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 31077706)

  • 1. Electrophysiologic and molecular mechanisms of a frameshift NPPA mutation linked with familial atrial fibrillation.
    Menon A; Hong L; Savio-Galimberti E; Sridhar A; Youn SW; Zhang M; Kor K; Blair M; Kupershmidt S; Darbar D
    J Mol Cell Cardiol; 2019 Jul; 132():24-35. PubMed ID: 31077706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of insulin signaling may contribute to atrial fibrillation and atrial electrical remodeling in type 1 diabetes.
    Polina I; Jansen HJ; Li T; Moghtadaei M; Bohne LJ; Liu Y; Krishnaswamy P; Egom EE; Belke DD; Rafferty SA; Ezeani M; Gillis AM; Rose RA
    Proc Natl Acad Sci U S A; 2020 Apr; 117(14):7990-8000. PubMed ID: 32198206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ion Channel and Structural Remodeling in Obesity-Mediated Atrial Fibrillation.
    McCauley MD; Hong L; Sridhar A; Menon A; Perike S; Zhang M; da Silva IB; Yan J; Bonini MG; Ai X; Rehman J; Darbar D
    Circ Arrhythm Electrophysiol; 2020 Aug; 13(8):e008296. PubMed ID: 32654503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atrial fibrillation and electrophysiology in transgenic mice with cardiac-restricted overexpression of FKBP12.
    Pan Z; Ai T; Chang PC; Liu Y; Liu J; Maruyama M; Homsi M; Fishbein MC; Rubart M; Lin SF; Xiao D; Chen H; Chen PS; Shou W; Li BY
    Am J Physiol Heart Circ Physiol; 2019 Feb; 316(2):H371-H379. PubMed ID: 30499712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Underlying mechanism of atrial fibrillation-associated Nppa-I137T mutation and cardiac effect of potential drug therapy.
    Huang Y; Wang LL; Liu ZB; Chen C; Ren X; Luo AT; Ma JH; Antzelevitch C; Barajas-Martínez H; Hu D
    Heart Rhythm; 2024 Feb; 21(2):184-196. PubMed ID: 37924963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inward Rectifier K
    Pluteanu F; Seidl MD; Hamer S; Scholz B; Müller FU
    J Am Heart Assoc; 2020 Dec; 9(23):e016144. PubMed ID: 33191843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Natriuretic Peptide Oligomers Cause Proarrhythmic Metabolic and Electrophysiological Effects in Atrial Myocytes.
    Yang Z; Subati T; Kim K; Murphy MB; Dougherty OP; Christopher IL; Van Amburg JC; Woodall KK; Barnett JV; Murray KT
    Circ Arrhythm Electrophysiol; 2022 Mar; 15(3):e010636. PubMed ID: 35212578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Wild-Type and Mutant Forms of Atrial Natriuretic Peptide on Atrial Electrophysiology and Arrhythmogenesis.
    Hua R; MacLeod SL; Polina I; Moghtadaei M; Jansen HJ; Bogachev O; O'Blenes SB; Sapp JL; Legare JF; Rose RA
    Circ Arrhythm Electrophysiol; 2015 Oct; 8(5):1240-54. PubMed ID: 26227000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential role of atrial natriuretic peptide in the effects of Angiotensin-(1-7) in a chronic atrial tachycardia canine model.
    Zhao J; Liu T; Liu E; Li G; Qi L; Li J
    J Renin Angiotensin Aldosterone Syst; 2016; 17(1):1470320315627409. PubMed ID: 27009283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Augmented potassium current is a shared phenotype for two genetic defects associated with familial atrial fibrillation.
    Abraham RL; Yang T; Blair M; Roden DM; Darbar D
    J Mol Cell Cardiol; 2010 Jan; 48(1):181-90. PubMed ID: 19646991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutation in
    Cheng C; Liu H; Tan C; Tong D; Zhao Y; Liu X; Si W; Wang L; Liang L; Li J; Wang C; Chen Q; Du Y; Wang QK; Ren X
    FASEB J; 2019 Aug; 33(8):8878-8891. PubMed ID: 31034774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Knock-in gain-of-function sodium channel mutation prolongs atrial action potentials and alters atrial vulnerability.
    Blana A; Kaese S; Fortmüller L; Laakmann S; Damke D; van Bragt K; Eckstein J; Piccini I; Kirchhefer U; Nattel S; Breithardt G; Carmeliet P; Carmeliet E; Schotten U; Verheule S; Kirchhof P; Fabritz L
    Heart Rhythm; 2010 Dec; 7(12):1862-9. PubMed ID: 20728579
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human induced pluripotent stem cell-derived atrial cardiomyocytes carrying an SCN5A mutation identify nitric oxide signaling as a mediator of atrial fibrillation.
    Hong L; Zhang M; Ly OT; Chen H; Sridhar A; Lambers E; Chalazan B; Youn SW; Maienschein-Cline M; Feferman L; Ong SG; Wu JC; Rehman J; Darbar D
    Stem Cell Reports; 2021 Jun; 16(6):1542-1554. PubMed ID: 34019817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NPR-C (Natriuretic Peptide Receptor-C) Modulates the Progression of Angiotensin II-Mediated Atrial Fibrillation and Atrial Remodeling in Mice.
    Jansen HJ; Mackasey M; Moghtadaei M; Liu Y; Kaur J; Egom EE; Tuomi JM; Rafferty SA; Kirkby AW; Rose RA
    Circ Arrhythm Electrophysiol; 2019 Jan; 12(1):e006863. PubMed ID: 30636477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atrial natriuretic peptide frameshift mutation in familial atrial fibrillation.
    Hodgson-Zingman DM; Karst ML; Zingman LV; Heublein DM; Darbar D; Herron KJ; Ballew JD; de Andrade M; Burnett JC; Olson TM
    N Engl J Med; 2008 Jul; 359(2):158-65. PubMed ID: 18614783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of the action potential duration is required for sustained atrial fibrillation.
    Avula UMR; Abrams J; Katchman A; Zakharov S; Mironov S; Bayne J; Roybal D; Gorti A; Yang L; Iyer V; Waase M; Saluja D; Ciaccio EJ; Garan H; Marks AR; Marx SO; Wan EY
    JCI Insight; 2019 Apr; 5(11):. PubMed ID: 31021331
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuating persistent sodium current-induced atrial myopathy and fibrillation by preventing mitochondrial oxidative stress.
    Avula UMR; Dridi H; Chen BX; Yuan Q; Katchman AN; Reiken SR; Desai AD; Parsons S; Baksh H; Ma E; Dasrat P; Ji R; Lin Y; Sison C; Lederer WJ; Joca HC; Ward CW; Greiser M; Marks AR; Marx SO; Wan EY
    JCI Insight; 2021 Oct; 6(23):. PubMed ID: 34710060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of SCN5A in mouse heart mimics human syndrome of enhanced atrioventricular nodal conduction.
    Liu GX; Remme CA; Boukens BJ; Belardinelli L; Rajamani S
    Heart Rhythm; 2015 May; 12(5):1036-45. PubMed ID: 25623181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic Ablation of TASK-1 (Tandem of P Domains in a Weak Inward Rectifying K
    Schmidt C; Wiedmann F; Beyersdorf C; Zhao Z; El-Battrawy I; Lan H; Szabo G; Li X; Lang S; Korkmaz-Icöz S; Rapti K; Jungmann A; Ratte A; Müller OJ; Karck M; Seemann G; Akin I; Borggrefe M; Zhou XB; Katus HA; Thomas D
    Circ Arrhythm Electrophysiol; 2019 Sep; 12(9):e007465. PubMed ID: 31514528
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrical and structural remodeling contribute to atrial fibrillation in type 2 diabetic db/db mice.
    Bohne LJ; Jansen HJ; Daniel I; Dorey TW; Moghtadaei M; Belke DD; Ezeani M; Rose RA
    Heart Rhythm; 2021 Jan; 18(1):118-129. PubMed ID: 32911049
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.